It participated in the IRAK4/IRAK1/AP-1/AKR1B10 signaling pathway and AUF1-mediated post-transcriptional regulation of AKR1B10 expression to regulate cancer stemness and drug resistance in HCC. Here, IRAK4 is linked to hepatocellular carcinoma.